| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.089 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.074 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |